Advances in the application of nicotinamide in dermatology
- Author:
- No author available
- Journal Title:
- INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY
- Issue:
- 2
- DOI:
- 10.3760/cma.j.issn.1673-4173.2009.02.010
- Key Word:
- 烟酰胺;皮肤疾病;治疗应用;Niacinamide;Skin diseases;Therapeutic uses
Abstract： Recent studies have shown that nicotinamide adenine dinucleotide(NAD)is not only a co-enzyme in cellular oxidation.reduction reactions.but also a substrate for reactions catalyzed by mono (ADP-ribose) transferases,poly (ADP-ribose) polymemses and acetylase,and it play important roles in numerous cellular physiologic functions.Nicotinamide is not only a precursor for the synthesis of NAD,but also an inhibitor of NAD-consuming enzymes.Besides pellagra,nicotinamide has been used to ireat immune bullous diseases,atopic dermatitis,rosacea and aene,and so on.Moreover,nicotinamide has shown a favorable perspective in anti-skin aging and cosmetic dermatology.The safety of topical nicotinamide has been already confirmed.but a forlnal safety evaluation routinely designed for a new drug has not been performed for oral nicotinamide at high dose.
- [1]Damian DL,Patterson CR,Barnetson RS,etc.UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide.[J].2008,128(2).
- [2]Draelos, Z. D..Clinical Situations Conducive to Proactive Skin Health and Anti-Aging Improvement[J].2008,13(1).
- [3]Bissett DL,Oblong JE,Berge CA.Niacinamide: A B vitamin that improves aging facial skin appearance.[J].2005,31(7 Pt.2).
- [4]Neil M, Niren,Helen M, Torok.The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial.[J].2006,77(1 Suppl).
- [5]Knip, M.,Douek, I. F.,Moore, W. P.,etc.Safety of high-dose nicotinamide: a review[J].2000,43(11).
- [6]Kang HT,Lee HI,Hwang ES.Nicotinamide extends replicative lifespan of human cells.[J].2006,5(5).
- [7]Gale EA,Bingley PJ,Emmett CL,etc.European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.[J].2004,363(9413).
- [8]Imaizumi A,Kawakami T,Takahama H,etc.Moisturizing effects of topical nicotinamide on atopic dry skin.[J].2005,44(3).
- [9]Daniel, J.,Marechal, Y.,Van Gool, F.,etc.Nicotinamide inhibits B lymphocyte activation by disrupting MAPK signal transduction[J].2007,73(6).
- [10].Final report of the safety assessment of niacinamide and niacin.[J].2005,24(Suppl.5).
- [11]Mohammad Reza Namazi.Nicotinamide as a potential addition to the anti-atopic dermatitis armamentarium[J].2004,4(6).
- [12]F. Wojnarowska,G. Kirtschig,A.S. Highet,etc.Guidelines for the management of bullous pemphigoid[J].2002,147(2).
- [13]Smiles K,Draelos ZD,Matsubara A.The effect of 2% niacinamide on facial sebum production.[J].2006,8(2).
- [14]Jacobson EL,Benavente CA.Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes.[J].2008,44(4).
- [15]Schwartz RA,Hegyi V,Hegyi J.Pellagra: Dermatitis, dementia, and diarrhea.[J].2004,43(1).
- [16]Mohammad R. Namazi.Nicotinamide in dermatology: a capsule summary[J].2007,46(12).